QUSVM

Qiming U.S. Ventures Management Portfolio holdings

AUM $23.6M
This Quarter Return
+116.23%
1 Year Return
-18.39%
3 Year Return
+715.34%
5 Year Return
10 Year Return
AUM
$89.7M
AUM Growth
+$89.7M
Cap. Flow
-$279M
Cap. Flow %
-310.69%
Top 10 Hldgs %
100%
Holding
8
New
Increased
1
Reduced
2
Closed
2

Top Buys

1
TRML icon
Tourmaline Bio
TRML
$2.29M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
KRRO icon
1
Korro Bio
KRRO
$217M
$33.1M 36.93% 368,085
JSPR icon
2
Jasper Therapeutics
JSPR
$45.5M
$27.3M 30.41% 928,964 -7,590,684 -89% -$223M
TRML icon
3
Tourmaline Bio
TRML
$601M
$17M 18.94% 741,691 +100,000 +16% +$2.29M
HLVX icon
4
HilleVax
HLVX
$105M
$9.29M 10.36% 558,923
VTYX icon
5
Ventyx Biosciences
VTYX
$171M
$2.27M 2.53% 412,225 -274,145 -40% -$1.51M
KZR icon
6
Kezar Life Sciences
KZR
$28.9M
$747K 0.83% 828,711
ELEV
7
DELISTED
Elevation Oncology
ELEV
-2,370,142 Closed -$1.27M
ICVX
8
DELISTED
Icosavax, Inc. Common Stock
ICVX
-3,510,228 Closed -$55.3M